SD大鼠母体低硒对子代哺乳期生长发育的影响

目的:探讨母体长期处于低硒状态下是否对子代哺乳期生长发育影响.方法:将正常成年雌性SD大鼠随机分为低硒实验组(SR)和正常对照组(NC),分别使用常硒和自制低硒饲料喂养,4周后,确定低硒动物模型建立成功后并分别进行合笼.从子代出生开始,通过记录两组子代大鼠哺乳期的各项生长发育指标并检测子代体内硒含量,探讨母体低硒对子代哺乳期生长发育的影响.结果:低硒实验组子代SD大鼠体长及体重均低于正常对照组,并且低硒实验组子代SD大鼠的死亡率较正常对照组高;低硒实验组子代SD大鼠肝脏、心脏、肾脏以及血液中的硒含量均明显低于正常对照组;低硒实验组子代SD大鼠的心脏、肝脏及肾脏重量,均低于正常对照组.结论:母体长期处于低硒状态下,将对子代哺乳期的生长发育造成严重影响.     

高糖高脂膳食诱导大鼠肝脏ChREBPmRNA表达

目的：观察高糖高脂膳食对大鼠肝组织碳水化合物反应元件结合蛋白（ChREBP）表达的影响。方法：16只雄性SD大鼠随机分为2组,对照组给予普通饲料,高糖高脂组给予高糖高脂饲料。6周后,检测血脂和肝组织中ChREBP表达水平。结果：高糖高脂膳食组ChREBPmRNA表达水平、血总甘油三酯、总胆固醇和高密度脂蛋白浓度均显著高于对照组（P〈0．05）;血低密度脂蛋白明显低于对照组（P〈0．05）。结论：高搪高脂膳食能引起肝脏组织中碳水化合物反应元件结合蛋白表达增加。     

多次采血对Wistar大鼠脏器系数的影响

目的研究不同时间间隔经眼眶静脉丛多次采血后,对雄性Wistar大鼠重要脏器系数的影响。方法实验组分别间隔3 d、7 d、10 d,经眼眶静脉丛采血,每次采血1 mL,共采3次。对照组于实验组最后一次采血时采血一次,采血1 mL。每次采血前称量体重,于最后一次采血后将大鼠处死,取心脏、肝脏、肾脏、脾脏、胸腺,称量脏器重量,计算脏器系数。结果间隔3 d多次采血,大鼠的肝、肾系数差异具有显著性（P〈0.05）,间隔7 d、10 d多次采血,大鼠的各脏器系数差异无显著性。结论间隔3 d多次采血对大鼠的肝、肾系数有影响,间隔7 d、10 d多次采血对各脏器系数均无影响。     

生长休止蛋白7在成年大鼠肾脏、心脏和肝脏中的差异表达

目的研究生长休止蛋白7（Gas7）在成年大鼠肾脏、心脏和肝脏的表达。方法成年SD大鼠16只,分别采用逆转录聚合酶链反应（RT-PCR）方法和免疫组织化学方法检测Gas7基因mRNA和蛋白在成年SD大鼠肾脏、心脏和肝脏的表达,并进行图像分析和统计学处理。结果RT—PCR结果显示,Gas7mRNA在肾脏高表达,在心脏的表达弱于肾脏（P〈0．05）,而在肝脏的表达最弱,基本检测不到。免疫组化结果显示,在肾脏中,Gas7免疫阳性产物在近髓肾单位的近曲小管呈强阳性反应,在集合管表达较弱,在肾小球和其余肾小管未见表达;在心脏中,Gas7免疫阳性产物均匀分布于心肌细胞,呈中等强度反应,弱于肾脏（P〈O．05）;在肝脏中,Gas7蛋白未见明显表达,与其mRNA在肝脏的表达相似。结论Gas7在大鼠肾脏、心脏和肝脏表达的不同,尤其在肾脏组织分布的差异性,提示Gas7在成年大鼠肾脏和心脏结构以及功能的维持中可能起着重要作用。     

不同性别及长期运动对大鼠肝脏羟自由基代谢与脂质过氧化作用的影响

目的：观察长期运动对大鼠肝脏自由基的影响,及不同性别间可能的差异。方法：SD大鼠随机分为雄性运动组（MEG）,雄性静息组（MSG）,雌性运动组（FEG）,雌性静息组（FSG）。运动组游泳每天2小时,每周游泳5d（休息2d）,持续3个月。期满后检测肝脏OH·及MDA水平,并分析性别差异。结果：抑制OH·能力FEG（18．78±2．77U／mg pro）显著高于FSG（1g．36±3．94U／mg pro）（P〈0．01）,MEG（16．56±3．44U／mg pro）显著高于MSG（12．85±2．00U／mg pro）（P〈0．05）;MDA含量FEG（0．499±0．095nmol／mg pro）显著低于FSG（0．625±0．073nmol／mg pro）（P〈0．01）,MEG与MSG之间无显著差异;肝脏OH·与MDA水平无显著相关。结论：长期运动可降低雌雄大鼠肝脏OH·含量,无性别差异;降低雌性但不影响雄性肝脏脂质过氧化水平,性别差异明显。     

维生素D3对自发性高血压大鼠靶器官炎症的影响

目的探索维生素D3与高血压和炎症的关系。方法自发性高血压大鼠20只,随机分为对照组和实验组,各10只。实验组大鼠腹腔注射维生索D3制剂3μg／kg（溶于20％丙二醇0．5mL中）,每周2次;对照组仅腹腔注射丙二醇0．5mL,两组均干预12周。实验过程中监测大鼠血压变化。干预前后,酶联免疫法检测血清25（OH）D3、钙、白细胞介素-6（IL-6）、基质金属蛋白酶-9（MMP-9）的浓度;计算肾脏-体重比和心脏-体重比;HE染色观察两组大鼠肾脏、心脏、主动脉、小动脉组织病理改变。结果实验组和对照组在干预前血压无差异显著性（P〉0．05）;干预后,实验组和对照组大鼠平均收缩压分别为（157±9）mmHg和（173±8）mmHg（P〈0．05）。实验组的血清25（OH）D3、血钙水平比对照组高（P〈0．05）,IL-6、MMP-9水平实验组比对照组低（P〈0．05）。实验组的心脏-体重比小于对照组（P〈0．05）。实验组的肾脏、心脏和小动脉高血压、炎性损害明显轻于对照组。结论规律的维生素D3用药能够抑制炎症因子IL-6、MMP-9的产生,抑制机体炎症反应,调节控制血压。     

鱼油对断奶大鼠脏器指数及肠道菌群影响的研究

目的探讨鱼油对断奶大鼠脏器指数及肠道菌群的影响。方法选取（21±3）d日龄断奶SD大鼠96只,雌雄各半,随机分为2组,实验组饲喂添加0．5％鱼油的饲料,对照组饲喂正常饲料。分别于第7、14、21、28天处死各组大鼠12只,分别测定大鼠肝脏指数、胸腺指数及脾脏指数;应用梯度稀释法和培养法测定大鼠4种肠道正常菌群,即肠杆菌、双歧杆菌、乳酸杆菌、葡萄球菌。结果实验组第7天脾脏指数与对照组相比差异有显著性（P〈0．05）,第28天肝脏指数和胸腺指数与对照组相比差异有显著性（P〈0．05）;实验组第7、14和21天肠道内肠杆菌数量与对照组相比差异有显著性（P〈0．05）,第7天大鼠肠道内葡萄球菌数量与对照组相比差异有显著性（P〈0．05）,第14天大鼠肠道内葡萄球菌数量与对照组相比差异有非常显著性（P〈0．01）,实验组大鼠肠道内乳酸杆菌和双歧杆菌数量与对照组相比虽有所增高,但差异无显著性（P〉0．05）。结论鱼油可以明显提高断奶大鼠的脏器指数,并且可通过增加断奶大鼠肠道内双歧杆菌和乳酸杆菌数量,降低肠道内肠杆菌和葡萄球菌数量,进而调节断奶大鼠的肠内菌群,改善肠道内环境。     

转基因EGFP小鼠的主要脏器重量及脏器系数

目的测定转基因C57BL／6-Tg（ACTB—EGFP）1osb／J（EGFP）小鼠主要脏器重量和脏器系数。方法实验选用5～6周雄性、6～7周雌性小鼠各15只,用sartorius电子天平分别测定体重和9个主要脏器重量,计算脏器系数,并对雌雄脏器重量和脏器系数之间进行比较。结果雌雄小鼠脏器重量间比较,雄性鼠体重明显大于雌性的体重（P〈0．01）;心、肝、肺、肾、肾上腺的重量间差异极显著（P〈0．01）;脾脏比较差异显著（P〈0．05）;雌雄间脏器系数比较,肺、脑、肾上腺间差异极显著（P〈0．01）,心、肝、脾、肾脏间差异不显著（P〉0．05）。结论转基因EGFP小鼠不同性别间脏器重量及脏器系数间有一定的差异,为相关研究打下了基础。     

Fmr1基因敲除小鼠脏器重量和脏器系数的比较分析

目的通过对Fmr1基因敲除小鼠雌雄两性和FVB小鼠的脏器重量和脏器系数进行比较分析,了解其脏器重量的差异,探讨Fmr1基因对动物生长发育等方面的影响。方法分别测定Fmr1基因敲除小鼠雌雄两性和FVB小鼠内脏器官的绝对重量和脏器系数,并进行统计学处理和分析。结果相同年龄的Fmr1基因敲除小鼠雄性的体重、心、肺、肝和肾的绝对重量均极显著的大于雌性（P〈0.01）。雌雄间脏器系数除肾脏（P〈0.05）和脑（P〈0.01）外,其余无显著差异。与FVB小鼠比较,Fmr1基因敲除小鼠心脏较轻（P〈0.01）,肾脏（P〈0.01）、体重和脑较重（P〈0.05）。脏器系数肾脏较大（P〈0.01）,心脏（P〈0.01）、脑和脾（P〈0.05）较小。结论Fmr1基因可影响动物的某些脏器重量和脏器系数。     

霍山石斛胶囊对高脂血症大鼠血脂和脂质过氧化水平的影响

目的：探讨霍山石斛胶囊（Dendrobium huoshenese capsule,DHC）对高脂血症大鼠的血脂影响及脂质过氧化水平作用。方法：采用高脂饲料建立实验性高脂血症大鼠模型,而后进行低、中、高三种剂量的DHC和阳性对照药血脂康实验性治疗,实验8周后,取大鼠血清、肝脏,检测模型大鼠血清总固醇（Total cholesterol,TC）、甘油三酯（Triglyceride,TG）、低密度脂蛋白胆固醇（Low density lipoprotein cholesterol,LDL—C）、高密度脂蛋白胆固醇（High density lipoprotein cholesterol,HDL—C）含量,并计算动脉粥样硬化指数（Atherosclerosis index,AI）;同时测定血清和肝脏超氧化物歧化酶（Superoxide dismutase,SOD）活性及丙二醛（Malondialdehyde,MDA）含量;并计算肝系数,制备大鼠肝脏石蜡切片观察其病理学变化。结果：与高脂血症模型组相比,DHC中、高剂量组和血脂康组能显著降低高脂血大鼠血清TC、TG、LDL-C,升高HDL—C,表现为AI降低;低剂量的DHC能升高HDL—C,但在降低血清TC、TG、LDL．C和AI上无统计学差异（P〉0．05）;除DHC低剂量组对血清SOD活性升高作用不显著外（P〉0．05）,其他各浓度给药组均能显著升高血清和肝脏SOD活性,降低血清和肝脏MDA含量及肝系数（P〈0．05,P〈0．01）;同时,DHC各给药组还可不同程度降低高脂血症大鼠肝细胞的脂肪变性程度。结论：霍山石斛胶囊能调节血脂代谢异常,增强抗氧化能力,具有防治脂肪肝和抗动脉粥样硬化作用。     

纳米氧化锌经口染毒对C57BL/6J小鼠外周脏器的影响*

目的:探讨纳米氧化锌经口染毒60 d对C57BL/6J小鼠多种外周脏器的损伤作用。方法:20只雄性C57BL/6J小鼠随机分为对照组和实验组,每组10只,实验组将纳米氧化锌溶液以20 mg/kg体重的剂量连续灌胃染毒60 d,对照组给予相应量的生理盐水;小鼠每周称重一次,染毒结束后,眼球取血,检测血糖、血脂、肝功能和肾功能相关指标,以及血清中炎症因子PAF、IL-6和TNF-α含量;取心脏、肝脏、脾脏、肺、肾脏和小肠组织制备病理切片,HE染色后,观察组织形态学变化。结果:实验组和对照组之间的体重无显著性差异;与正常对照组比较,实验组大鼠血中白蛋白(ALB)、白蛋白/球蛋白比值(A/G)、碱性磷酸酶(ALP)、谷草/谷丙转氨酶比值(S/L)、尿酸(UA)和尿素氮(BUN)含量明显升高(P＜0.05或 P＜0.01);两组间血清中炎症因子含量无显著差异。病理学检查发现,实验组心肌中部分区域出现浊肿,肝脏出现轻度炎性病变(灶性或小灶性坏死),脾脏色素沉着减少,肺部出现轻或中度间质性炎症,肾脏和小肠未见明显病理改变。结论:纳米氧化锌经口染毒60 d未引起C57BL/6J小鼠血液系统炎症,但可诱导心脏、肝脏、脾脏和肺脏出现轻度的病理变化,并导致肝脏和肾脏的功能异常。     

The effect of consuming different proportions of hummer fish on biochemical and histopathological changes of hyperglycemic rats

Hammour fish (grouper fish) are known to be of great nutritional value for human consumption, as their protein has a high biological value and contains all the essential amino acids. Grouper fish are also a good source of minerals, vitamins, and fats that contain essential fatty acids. Thus, the current study aims to know the effect of different proportion of hummer fish on biochemical and histopathological changes of hyperglycemic rats. Twenty-four (24) Sprague Dawley-strain male albino rats, which weighed 150 ± 10 g, were divided into four groups. One group served as the negative control (normal), while the others were rendered diabetic using alloxan. One of the diabetic groups was considered the positive control and fed a standard diet, whereas the remaining two groups were fed with a 20% and 25% hammour fish diet for 28 days. At the end of the experiment, blood samples were taken from all the rats, and their organs were removed and subjected to biochemical analysis. The results indicated that the group fed with the 25% hammour fish diet exhibited significantly lower levels of liver, kidney, and heart damage, along with lower levels of serum glucose, total cholesterol, triglycerides, LDL, GOT, GPT and ALP, as compared to the positive control. The urea and creatinine levels were significantly higher for the rats that were fed the 20% hammour fish diet than for those in the positive control. The histopathological study of the heart showed a slight improvement of the heart tissues with the increase of hammour fish intake compare to the positive control, while kidney of rat from group 4, which were fed 25% hammour fish, showed granularity of epithelial lining glomerular tufts.     

Potential protective effect of HSCAS and bentonite against dietary aflatoxicosis in rat: with special reference to chromosomal aberrations.

Bentonite and hydrated sodium calcium aluminsilicate (HSCAS) were added at a level of 0.5% (w/w) to the diets containing 2.5 mg aflatoxins (AF) per kg diet and fed to male mature rats for 15 successive days. Aflatoxin alone significantly decreased feed intake and altered serum biochemical parameters of liver and kidney functions. Aflatoxin caused chromosomal aberrations in bone marrow cells. Bentonite or HSCAS did not alter any of the parameters measured. The addition of bentonite or HSCAS to the AF-contaminated diet diminished most of the deleterious effects of the aflatoxin. Pathological examinations of liver and kidney proved that both bentonite and HSCAS were hepatonephroprotective agents against aflatoxicosis. The cytogenetic findings demonstrated that the addition of bentonite or HSCAS to AF-contaminated diet suppressed chromosomal aberrations. These findings indicated that bentonite and HSCAS could diminished many of the adverse effect of dietary AF in rats.     

Effects of fish oil on hypertension, plasma lipids, and tumor necrosis factor-alpha in rats with sucrose-induced metabolic syndrome

Dietary fish oil rich in (n-3) fatty acids plays an important role in reducing abnormalities associated with the metabolic syndrome and mortality from coronary heart disease. We investigated the effects of dietary fish oil on the metabolic syndrome in a high-sucrose-fed rat model. The model was achieved by the administration of 30% sucrose in drinking water in male Wistar rats during 21 weeks. After the metabolic syndrome rat model was established, fish oil was administered during 6 weeks. The metabolic syndrome rats showed significant increases in body weight, systolic blood pressure, serum insulin, total lipids, triacylglycerols, cholesterol, free fatty acids, LDL, total proteins, albumin, and serum tumor necrosis factor-alpha (TNF-alpha). They also presented abdominal and epididymal fat accumulation and fatty liver. After fish oil diet administration, metabolic syndrome rats had a significant reduction in blood pressure, serum insulin, triacylglycerols, cholesterol, free fatty acids, and total lipids, but no change was observed in TNF-alpha concentration or fat accumulation. In conclusion, fish oil reversed the alterations on metabolic parameters and blood pressure exerted by sucrose administration, although it had no effect on TNF-alpha production and adiposity. This confirms the theory that the molecular etiology of the metabolic syndrome is multifactorial, as is the effect of n-3 polyunsaturated fatty acids (PUFAs) upon it, having complex and multifaceted actions.     

Comparative studies on lipid peroxidation of microsomes and mitochondria obtained from different rat tissues: effect of retinyl palmitate

The effect of retinyl palmitate on the polyunsaturated fatty-acid composition, chemiluminescence and peroxidizability index of microsomes and mitochondria obtained from rat liver, kidney, brain, lung and heart, was studied. After incubation of microsomes and mitochondria in an ascorbate Fe++ system (120 min at 37 degrees C) it was observed that the total cpm/mg protein originated from light emission: chemiluminescence was lower in liver microsomes, mitochondria and kidney microsomes in the vitamin A group than in the control group. In mitochondria obtained from control rats, the most sensitive fatty acids for peroxidation were arachidonic acid C20:4 n6 in liver and docosahexaenoic acid C22:6 n3 in kidney and brain. In microsomes obtained from control rats, the most sensitive fatty acids for peroxidation were linoleic acid C18:2 n6 and C20:4 n6 in liver and C22:6 n3 in kidney. Changes in the most polyunsaturated fatty acids were not observed in organelles obtained from lung and heart. As a consequence the peroxidizability index, a parameter based on the maximal rate of oxidation of fatty acids, showed significant changes in liver, kidney and brain mitochondria, while in microsomes changes were significant in liver and kidney. These changes were less pronounced in membranes derived from rats receiving vitamin A. Our results confirm and extend previous observations that indicated that vitamin A may act as an antioxidant protecting membranes from deleterious effects.     

Chemoprotective effect of omega-3 fatty acids on thioacetamide induced hepatic fibrosis in male rats

The current study was designed to investigate the possible protective effect of omega-3 fatty acids from fish oil on hepatic fibrosis induced by thioacetamide (TAA) in male rats. The experimental animals were divided into four groups. The first group was received saline solution and served as control. The second group was given 250 mg/kg body weight of TAA. The third group was treated with omega-3 fatty acids and TAA. The fourth group was given saline solution and supplemented with omega-3 fatty acids. Treatment of rats with TAA for three and six weeks resulted in a significant decrease in body weight gain, while the value of liver/body weight ratio was statistically increased. Furthermore, the levels of serum alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma glutamyl transferase and total bilirubin were significantly increased. After three weeks of exposure to only TAA, liver sections showed an abnormal morphology characterized by noticeable fibrosis with the extracellular matrix collagen contents and damage of liver cells’ structure. Liver sections from rats treated with only TAA for six weeks revealed an obvious increase in extracellular matrix collagen content and bridging fibrosis. Treating TAA-intoxicated rats with omega-3 fatty acids significantly attenuated the severe physiological and histopathological changes. Finally, the present investigation suggests that omega-3 fatty acids could act against hepatic fibrosis induced by TAA due to its antioxidant properties, thus supporting its use in hepatic fibrosis therapy.     

SD大鼠酒精性脂肪肝模型的监测分析

目的：通过血清生化指标和病理学的监测分析来建立标准的SD大鼠酒精性脂肪肝动物模型。方法：选取40只SD大鼠,随机分为两组,模型组采用直接饮酒法,于第8、12和20周时检测大鼠血清生化指标：丙氨酸氨基转移酶（ALT）、天门冬氨酸氨基转移酶（AST）、甘油三酯（TG）,并于第8、12周时随机采集5只大鼠肝组织,20周时采集剩余所有大鼠肝组织并进行病理学分析。结果：模型组于第8、12和20周时体重增长量均低于对照组（P〈0．01）,血清ALT、AST均高于对照组（P〈0．01）,第8周和12周时TG高于对照组（P〈0．01）。病理学结果显示肝组织从8周至20周呈现出酒精性脂肪肝、重度酒精性脂肪肝伴肝炎和酒精性肝纤维化等演变过程。结论：直接饮酒法可成功地复制出酒精性脂肪肝动物模型,通过监测分析可了解酒精性脂肪肝病变的整个过程,为今后建立酒精性脂肪肝和肝纤维化动物模型提供了理论参考。     

非酒精性脂肪肝病大鼠肝脏SOCS-3的表达与吡格列酮干预研究

目的：探讨SOCS-3在非酒精性脂肪肝病（NAFLD）发病中的作用以及吡格列酮的干预作用。方法：29只雄性SD大鼠随机分为正常对照组（8只）,高脂饮食组（21只）。饲养8周后,从高质饮食组随机抽取5只大鼠证实造模成功后,将该组余下的16只大鼠继续以高脂饲料喂养,并随机分为NAFLD对照组（8只）;吡格酮干预组（8只）,予以吡格列酮3mg·kg^-1·d^-1灌胃。16周末,处死所有大鼠,检测血糖、血胰岛素、血脂、肝脏SOCS-3mRNA和SREBP-lcmRNA表达及肝脏病理学。结果：与正常对照组相比,NAFLD组血糖、血胰岛素、血脂、肝脏脂肪变水平及肝组织SOCS-3mRNA、SREBPlCmRNA表达显著上调。吡格列酮干预组sOCS．3mRNA、SREBP-1cmRNA表达较NAFLD组下调,且血糖、血胰岛素、血脂、肝脏脂肪变水平下降。SOCS-3mRNA表达水平与胰岛素抵抗指数、SREBP．1cmRNA表达水平、肝脂肪变成显著正相关。结论：SOCS-3可能通过胰岛素抵抗及上调肝组织SREBP-lcmRNA表达参与NAFLD发病,吡格列酮能抑制肝脏SOCS-3的表达,对NAFLD有一定治疗作用。     

Why do omega-3 fatty acids lower serum triglycerides?

PURPOSE OF REVIEW: Fish oils rich in n-3 fatty acids reduce serum triglyceride levels. This well known effect has been shown to be caused by decreased very low-density lipoprotein triglyceride secretion rates in kinetic studies in humans. Animal studies have explored the biochemical mechanisms underlying this effect. Triglyceride synthesis could be reduced by n-3 fatty acids in three general ways: reduced substrate (i.e. fatty acids) availability, which could be secondary to increase in beta-oxidation, decreased free fatty acids delivery to the liver, decreased hepatic fatty acids synthesis; increased phospholipid synthesis; or decreased activity of triglyceride-synthesizing enzymes (diacylgylcerol acyltranferase or phosphatidic acid phosphohydrolase). RECENT FINDINGS: Rarely were experimental conditions used in rat studies physiologically relevant to the human situation in which 1.2% energy as n-3 fatty acids lowers serum triglyceride levels. Nevertheless, the most consistent effect of n-3 fatty acids feeding in rats is to decrease lipogenesis. Increased beta-oxidation was frequently, but not consistently, reported with similar numbers of studies reporting increased mitochondrial compared with peroxisomal oxidation. Inhibition of triglyceride-synthesizing enzymes was only occasionally noted. SUMMARY: As the vast majority of studies fed unphysiologically high doses of n-3 fatty acids, these findings in rats must be considered tentative, and the mechanism by which n-3 fatty acids reduce triglyceride levels in humans remains speculative.